Preliminary Efficacy Results from a Phase 1 Trial of Vector-Mediated Gene Transfer for Chronic Intractable Pain

被引：0
|
作者：
Fink, David
Mata, Marina
Wechuck, James
Krisky, David
Wolfe, Darren
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A412 / A412
页数：1
相关论文
共 50 条
  • [21] Transcriptional activity of novel ALDH1L1 promoters in the rat brain following AAV vector-mediated gene transfer
    Mudannayake, Janitha M.
    Mouravlev, Alexandre
    Fong, Dahna M.
    Young, Deborah
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2016, 3 : 16075
  • [22] PHASE I TRIAL OF AAV VECTOR-MEDIATED GENE DELIVERY OF AROMATIC L-AMINO ACID DECARBOXYLASE FOR PARKINSON'S DISEASE
    Muramatsu, Shin-ichi
    Fujimoto, Ken-ichi
    Kato, Seiya
    Asari, Sayaka
    Mizukami, Hiroaki
    Ikeguchi, Kunihiko
    Kawakami, Tadataka
    Urabe, Masashi
    Kume, Akihiro
    Sato, Toshihiko
    Watanabe, Eiju
    Ozawa, Keiya
    Nakano, Ima-haru
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1024 - 1024
  • [23] Endoscopic electroporation for inoperable oesophagogastric cancer: Preliminary results from a phase II clinical trial (The VECTOR Trial)
    Jackson, Andrew
    James, Eleanor
    Vohra, Ravinder
    Humes, David
    Parsons, Simon
    BRITISH JOURNAL OF SURGERY, 2022, 109
  • [24] SUMMARY OF SCREENING DATA FROM 19 PATIENTS WITH LATE-ONSET POMPE DISEASE FOR A PHASE I CLINICAL TRIAL OF AAV VECTOR-MEDIATED GENE THERAPY
    Hannah, William B.
    Case, Laura E.
    Walters, Crista
    Kishnani, Priya S.
    Koeberl, Dwight D.
    MOLECULAR GENETICS AND METABOLISM, 2019, 127 (03) : 274 - 274
  • [25] SUMMARY OF SCREENING DATA FROM 19 PATIENTS WITH LATE-ONSET POMPE DISEASE FOR A PHASE I CLINICAL TRIAL OF AAV VECTOR-MEDIATED GENE THERAPY
    Hannah, William B.
    Case, Laura E.
    Walters, Crista
    Kishnani, Priya S.
    Koeberl, Dwight D.
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (03) : 305 - 306
  • [26] Expression of Human α1-Antitrypsin in Mice and Dogs Following AAV6 Vector-mediated Gene Transfer to the Lungs
    Halbert, Christine L.
    Madtes, David K.
    Vaughan, Andrew E.
    Wang, Zejing
    Storb, Rainer
    Tapscott, Stephen J.
    Miller, A. Dusty
    MOLECULAR THERAPY, 2010, 18 (06) : 1165 - 1172
  • [27] Adeno-associated virus vector mediated gene therapy for Crigler Najjar syndrome: results of safety and efficacy from the dose escalation phase of the CareCN clinical trial
    D'Antiga, L.
    Beuers, U.
    Brunetti-Pierri, N.
    Baumann, U.
    Di Giorgio, A.
    Aronson, S.
    Hubert, A.
    Romano, R.
    Junge, N.
    Bosma, P.
    Bortolussi, G.
    Muro, A. F.
    Pavlyuk, M.
    Veron, P.
    Ronzitti, G.
    Collaud, F.
    Knuchel-Legendre, N.
    Mingozzi, F.
    Labrune, P.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A27 - A27
  • [28] Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction
    Dupré, L
    Trifari, S
    Follenzi, A
    Marangoni, F
    de Lera, TL
    Bernad, A
    Martino, S
    Tsuchiya, S
    Bordignon, C
    Naldini, L
    Aiuti, A
    Roncarolo, MG
    MOLECULAR THERAPY, 2004, 10 (05) : 903 - 915
  • [29] Histological evaluation of adenoviral vector-mediated gene transfer in retinal explants from normal and retinal degenerative (RD) mice.
    Cheng, M
    Runstadler, H
    Pang, J
    Barron, E
    Borrelli, MJ
    Blanks, JC
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S394 - S394
  • [30] Functional correction of T cells from Wiskott-Aldrich syndrome patients by retroviral and lentiviral vector-mediated gene transfer
    Dupré, L
    Trifari, S
    Marangoni, F
    Follenzi, A
    Bernad, A
    Martino, S
    Tsuchiya, S
    Naldini, L
    Bordignon, C
    Aiuti, A
    Roncarolo, MG
    MOLECULAR THERAPY, 2003, 7 (05) : S409 - S410
12345